Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 10.1007/s00259-020-04944-2)
Authors/Creators
Matthew J. Roberts
Andrew Morton
Peter Donato
Samuel Kyle
David A. Pattison
Paul Thomas
Geoff Coughlin
Rachel Esler
Nigel Dunglison
Robert A. Gardiner, Edith Cowan UniversityFollow
Suhail A. Doi
Louise Emmett
John Yaxley
Abstract
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature. Figure 2b is incorrect in the original paper.
Document Type
Response or Comment
Date of Publication
2021
ISSN
16197070
PubMed ID
32918575
Publication Title
European Journal of Nuclear Medicine and Molecular Imaging
Publisher
Springer Link
School
School of Medical and Health Sciences
Funders
Metro North Office of Research Avant Mutual Group Pty Ltd
Copyright
free_to_read
Comments
Roberts, M. J., Morton, A., Donato, P., Kyle, S., Pattison, D. A., Thomas, P., ... Yaxley, J. (2021). Correction to: 68 Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48, 655-656. https://doi.org/10.1007/s00259-020-04983-9